Gansu Provincial Hospital, 204 West Donggang R.D., Lanzhou, 730000, Gansu, China.
Ningxia Medical University, Yinchuan, 750004, Ningxia, China.
Surg Endosc. 2021 Dec;35(12):6397-6412. doi: 10.1007/s00464-021-08658-w. Epub 2021 Aug 9.
Whether perioperative administration is required in elective laparoscopic cholecystectomy (LC) in patients with low risk of infection remains controversial.
To investigate whether perioperative use of prophylactic antibiotics during elective LC can reduce the incidence of postoperative infection using a meta-analysis.
Pubmed, Cochrane Library, Embase, and reference lists were searched up to October 26, 2020, for randomized controlled trials (RCTs) of the perioperative use of antibiotics during LC. A systematic review with meta-analysis, meta-regression, and GRADE (Grading of Recommendations Assessment, Development and Evaluation) of the evidence was conducted. The Cochrane (RoB 2.0) tool was used to assess the risk of bias.
A total of 14 RCTs were ultimately included in the meta-analysis, involving a total of 4360 patients. The incidence of surgical site infections, distant infections, and overall infections was investigated and the relationship with the perioperative use of prophylactic antibiotics during LC analyzed. The results indicated that in low-risk patients undergoing elective LC, prophylactic antibiotics reduce the incidence of surgical site infections (RR 0.66; 95% CI 0.45-0.98), with a moderate GRADE of evidence, distant infections (RR 0.34; 95% CI 0.16-0.73), with a low GRADE of evidence and overall infections (RR 0.57; 95% CI 0.40-0.80), with a moderate GRADE of evidence.
The present meta-analysis demonstrates that the perioperative use of antibiotics in LC is effective in low-risk patients, possibly reducing the incidence of surgical site infections, distant infections, and overall infections. However, in view of the limitations of the study, it is recommended that studies with a more rigorous design (for downgraded factors) and larger sample size should be conducted in the future so that the conclusions above can be further verified through key result indicators.
择期腹腔镜胆囊切除术(LC)中是否需要预防性使用抗生素治疗感染低危患者仍存在争议。
采用荟萃分析方法研究 LC 术中预防性使用抗生素是否能降低术后感染的发生率。
检索 Pubmed、Cochrane 图书馆、Embase 及参考文献,查找截至 2020 年 10 月 26 日 LC 术中使用抗生素的随机对照试验(RCT)。对证据进行系统评价、荟萃分析、荟萃回归和 GRADE(推荐评估、制定与评估分级)评估。采用 Cochrane(RoB 2.0)工具评估偏倚风险。
共纳入 14 项 RCT 进行荟萃分析,共计 4360 例患者。调查手术部位感染、远处感染和总感染的发生率,并分析 LC 术中预防性使用抗生素与感染的关系。结果表明,在低危患者行择期 LC 中,预防性使用抗生素可降低手术部位感染的发生率(RR 0.66;95%CI 0.45-0.98),证据质量为中等级别,降低远处感染的发生率(RR 0.34;95%CI 0.16-0.73),证据质量为低等级别,降低总感染的发生率(RR 0.57;95%CI 0.40-0.80),证据质量为中等级别。
本荟萃分析表明,LC 中预防性使用抗生素对低危患者有效,可能降低手术部位感染、远处感染和总感染的发生率。但鉴于研究的局限性,建议未来开展设计更严谨(降级因素)、样本量更大的研究,通过关键结局指标进一步验证上述结论。